Portage Biotech Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Portage Biotech Inc Announces Listing On Canadian National Stock Exchange
Portage Biotech Inc. (the Company) announced that effective October 28, 2013, the common shares of Portage will be listed for trading on the Canadian National Stock Exchange (the CNSX), in US currency, under the symbol "PTB.U". Portage shares will also continue to be quoted and traded on the Over the Counter Bulletin Board of NASDAQ under the trading symbol "PTGEF".
Latest Developments for Portage Biotech Inc
Latest Key Developments in Biotechnology
- Tekmira Pharmaceuticals Corp announces proposed public offering of common stock
- La Jolla Pharmaceutical Co reports positive, top-line results from phase 2 clinical trial of gcs-100 in chronic kidney disease
- FDA designates Regado Biosciences Inc's REG1 in PCI as a fast track development program
- Omeros Corporation announces positive OMS721 Data in Serum from patients with aHUS
- Share this
- Digg this